DRUG · Mapped RxNorm record
Binimetinib
Normalized identity: binimetinibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer
NCT02451865
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Laboratory Biomarker Analysis
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBinimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Recurrent Non-Small Cell Lung Carcinomaunresolved
Stage IV Non-Small Cell Lung Cancerunresolved
Interventions
BinimetinibDRUG · verified · RxNorm: binimetinib
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Jonsson Comprehensive Cancer Centerlead sponsor
Novartis Pharmaceuticalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02451865 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.